Screener
Amgen AMGN Other Non-Cash Items
Other Non-Cash Items at other companies
Other financials
Where this comes from
Reported directly by Amgen in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The source filing: Amgen’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000318154-26-000126
| Line item | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Stock-based compensation expense | 240 | 242 |
| Deferred income taxes | (467) | (672) |
| Loss (gain) on equity securities | 301 | (741) |
| Other items, net | 8 | (73) |
| Changes in operating assets and liabilities, net of acquisitions: | ||
| Trade receivables, net | (680) | (1,823) |
| Inventories | (13) | 527 |
| Other assets | (322) | (407) |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is Amgen's other non-cash items?
- Amgen (AMGN) reported other non-cash items of -$75M in Q2 2026.
- How has Amgen's other non-cash items changed year-over-year?
- Amgen's other non-cash items decreased by 426.1% year-over-year, from $23M to -$75M.
- What is the long-term trend for Amgen's other non-cash items?
- Over 3 years (2021 to 2025), Amgen's other non-cash items has grown at a -17.1% compound annual growth rate (CAGR), from $262M to -$149M.
- What does other non-cash items mean?
- Other non-cash items affecting net income not classified elsewhere.
Ask your AI about Amgen's other non-cash items.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude